CONCLUSION
Patients taking immunosuppressant drugs are susceptible to COVID-19.
Immunosuppressant drugs like etanercept, mycophenolate mofetil,
sirolimus, cyclosporine and rituximab are prescribed for several reasons
such as autoimmune disease, cancer treatment, organ transplant, etc. It
is recommended that patients should continue with their treatment regime
in the midst of COVID-19 pandemic. Any changes pertaining to
immunosuppressant drugs like reducing dosage or halting medications
temporarily should be discussed with concerned healthcare providers.
Patients need to be aware of CDC guidelines on ways to prevent exposure
to the SARS nCoV-2 virus.
FUNDING : No funding for this work
CONFLICTS OF INTEREST : Nil
AUTHORS’ CONTRIBUTIONS :
DT: Concept, Data Collection, Writing & Review the manuscript, Design
MMG: Concept, Data Collection, Writing & Review the manuscript, Design
DI: Writing & Review the manuscript